Business description: PCAS
- synthesized pharmaceutical products (63.5%);
- fine chemicals (36.5%): technical fluids and additives for the lubricant industry, chemical additive synthesis. The group also offers photochemical and new technology products (photosensitive materials, photo-initiators, and polymers for photography, reprography, and micro-electronics).
At the end of 2022, the group had 7 production sites located in France (5), Canada and Finland.
France accounts for 76% of net sales.
Number of employees: 1,178
Sales by Activity: PCAS
| Fiscal Period: December | 2019 (EUR) | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) |
|---|---|---|---|---|
Pharmaceutical Synthesis | 128M | 135M | 120M | 144M |
Fine Speciality Chemicals | 73.25M | 58.92M | 67.41M | 82.72M |
Geographical breakdown of sales: PCAS
| Fiscal Period: December | 2019 (EUR) | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) |
|---|---|---|---|---|
France | 163M | 155M | 143M | 172M |
Other Areas | 38.01M | 38.92M | 44.36M | 54.3M |
Executive Committee: PCAS
| Manager | Title | Age | Since |
|---|---|---|---|
Gildas Barreyre
CEO | Chief Executive Officer | 43 | 2025-05-02 |
Eric Moissenot
DFI | Director of Finance/CFO | - | - |
Gérard Guillamot
CTO | Chief Tech/Sci/R&D Officer | - | 1999-02-28 |
Composition of the Board of Directors: PCAS
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 74 | 2014-02-28 | |
Janine Cossy
BRD | Director/Board Member | - | - |
Company details: PCAS
Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.28% | +0.07% | +52.75% | +138.78% | 1,258B | |
| +2.13% | +4.27% | +51.21% | +91.36% | 679B | |
| +0.68% | +1.54% | +33.83% | +112.47% | 518B | |
| +0.11% | +2.69% | +43.92% | +69.55% | 390B | |
| +1.38% | +0.27% | +72.42% | +45.30% | 367B | |
| +0.46% | +1.98% | +31.21% | +59.91% | 307B | |
| -0.06% | +2.09% | +7.02% | +39.23% | 293B | |
| +1.04% | -0.05% | +45.29% | +76.18% | 252B | |
| +1.46% | -0.59% | +42.48% | +125.82% | 210B | |
| Average | +0.61% | +1.05% | +42.24% | +84.29% | 475B | |
| Weighted average by Cap. | +0.59% | +1.18% | +45.47% | +96.90% |
